MSH2 and cancer: One patient with three MSI-H synchronous cancers showed normal MLH1, MSH2 and MSH6 expression in their cancers, the last patient demonstrated loss of MLH1 in one tumour, but MLH1, MSH2 and MSH6 expression in the other.